Antibody response to myelin oligodendrocyte glycoprotein and myelin basic protein depend on familial background and are partially associated with human leukocyte antigen alleles in multiplex families and sporadic multiple sclerosis

Journal of Neuroimmunology

Volumn 131, Issue 1-2, 2002, Pages 201-207

  Lutterotti, Andreas ^a   Reindl, Markus ^a   Gassner, Christoph ^b   Poustka, Katharina ^a   Schanda, Kathrin ^a   Deisenhammer, Florian ^a   Berger, Thomas ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

HLA; MOG; Multiple sclerosis; Multiplex families

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; HLA DR5 ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN M; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ADULT; AGED; ALLELE; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ARTICLE; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; GENETIC ASSOCIATION; HLA TYPING; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

ADULT; ALLELES; AUTOANTIBODIES; FAMILY HEALTH; FEMALE; GENE FREQUENCY; GENES, MHC CLASS II; GENOTYPE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; MYELIN PROTEINS; MYELIN-ASSOCIATED GLYCOPROTEIN;

EID: 0036791045     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00271-0     Document Type: Article

References (47)

1. Adelmann M., Wood J., Benzel I., Fiori P., Lassmann H., Matthieu J.M., Gardinier M.V., Dornmair K., Linington C. The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J. Neuroimmunol. 63:1995;17-27.
2. Amor S., Groome N., Linington C., Morris M.M., Dornmair K., Gardinier M.V., Matthieu J.M., Baker D. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J. Immunol. 153:1994;4349-4356.
3. Arnett F.C., Hamilton R.G., Reveille J.D., Bias W.B., Harley J.B., Reichlin M. Genetic studies of Ro (SS-A) and La (SS-B) autoantibodies in families with systemic lupus erythematosus and primary Sjogren's syndrome. Arthritis Rheum. 32:1989;413-419.
4. Besson Duvanel C., Honegger P., Matthieu J.M. Antibodies directed against rubella virus induce demyelination in aggregating rat brain cell cultures. J. Neurosci. Res. 65:2001;446-454.
5. Compston A. The genetics of multiple sclerosis. J. Neurovirology. 6(Suppl. 2):2000;S5-S9.
6. Ebers G.C., Paty D.W. CSF electrophoresis in one thousand patients. Can. J. Neurol. Sci. 7:1980;275-280.
7. Egg R., Reindl M., Deisenhammer F., Linington C., Berger T. Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis. Mult. Scler. 7:2001;285-289.
8. Forsthuber T.G., Shive C.L., Wienhold W., de Graaf K., Spack E.G., Sublett R., Melms A., Kort J., Racke M.K., Weissert R. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells. J. Immunol. 167:2001;7119-7125.
9. Genain C.P., Hauser S.L. Experimental allergic encephalomyelitis in the New World monkey Callithrix jacchus. Immunol. Rev. 183:2001;159-172.
10. Genain C.P., Nguyen M.H., Letvin N.L., Pearl R., Davis R.L., Adelman M., Lees M.B., Linington C., Hauser S.L. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J. Clin. Invest. 96:1995;2966-2974.
11. Genain C.P., Cannella B., Hauser S.L., Raine C.S. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 5:1999;170-175.
12. Grondal G., Kristjansdottir H., Gunnlaugsdottir B., Arnason A., Lundberg I., Klareskog L., Steinsson K. Increased number of interleukin-10-producing cells in systemic lupus erythematosus patients and their first-degree relatives and spouses in Icelandic multicase families. Arthritis Rheum. 42:1999;1649-1654.
13. Haase C.G., Guggenmos J., Brehm U., Andersson M., Olsson T., Reindl M., Schneidewind J.M., Zettl U.K., Heidenreich F., Berger T., Wekerle H., Hohlfeld R., Linington C. The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls. J. Neuroimmunol. 114:2001;220-225.
14. Johns T.G., Kerlero de Rosbo N., Menon K.K., Abo S., Gonzales M.F., Bernard C.C. Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J. Immunol. 154:1995;5536-5541.
15. Karni A., Bakimer-Kleiner R., Abramsky O., Ben-Nun A. Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis. Arch. Neurol. 56:1999;311-315.
16. Kerlero de Rosbo N., Honegger P., Lassmann H., Matthieu J.M. Demyelination induced in aggregating brain cell cultures by a monoclonal antibody against myelin/oligodendrocyte glycoprotein. J. Neurochem. 55:1990;583-587.
17. Koehler N.K., Genain C.P., Giesser B., Hauser S.L. The human T cell response to myelin oligodendrocyte glycoprotein: a multiple sclerosis family-based study. J. Immunol. 168:2002;5920-5927.
18. Laaksonen M., Pastinen T., Sjoroos M., Kuokkanen S., Ruutiainen J., Sumelahti M.L., Reijonen H., Salonen R., Wikstrom J., Panelius M., Partanen J., Tienari P.J., Ilonen J. HLA class II associated risk and protection against multiple sclerosis - a Finnish family study. J. Neuroimmunol. 122:2002;140-145.
19. Letterio J.J., Roberts A.B. Regulation of immune responses by TGF-beta. Annu. Rev. Immunol. 16:1998;137-161.
20. Liblau R.S., Bach J.F. Selective IgA deficiency and autoimmunity. Int. Arch. Allergy Immunol. 99:1992;16-27.
21. Lindert R.B., Haase C.G., Brehm U., Linington C., Wekerle H., Hohlfeld R. Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein. Brain. 122(Pt 11):1999;2089-2100.
22. Linington C., Bradl M., Lassmann H., Brunner C., Vass K. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am. J. Pathol. 130:1988;443-454.
23. Marrosu M.G., Muntoni F., Murru M.R., Spinicci G., Pischedda M.P., Goddi F., Cossu P., Pirastu M. Sardinian multiple sclerosis is associated with HLA-DR4: a serologic and molecular analysis. Neurology. 38:1988;1749-1753.
24. Menon K.K., Piddlesden S.J., Bernard C.C. Demyelinating antibodies to myelin oligodendrocyte glycoprotein and galactocerebroside induce degradation of myelin basic protein in isolated human myelin. J. Neurochem. 69:1997;214-222.
25. Newcombe J., Gahan S., Cuzner M.L. Serum antibodies against central nervous system proteins in human demyelinating disease. Clin. Exp. Immunol. 59:1985;383-390.
26. Olerup O., Hillert J. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens. 38:1991;1-15.
27. Olsson T., Baig S., Hojeberg B., Link H. Antimyelin basic protein and antimyelin antibody-producing cells in multiple sclerosis. Ann. Neurol. 27:1990;132-136.
28. Paterson P.Y., Day E.D., Whitacre C.C., Berenberg R.A., Harter D.H. Endogenous myelin basic protein-serum factors (MBP-SFs) and anti-MBP antibodies in humans. Occurrence in sera of clinically well subjects and patients with multiple sclerosis. J. Neurol. Sci. 52:1981;37-51.
29. Radway-Bright E.L., Ravirajan C.T., Isenberg D.A. The prevalence of antibodies to anionic phospholipids in patients with the primary antiphospholipid syndrome, systemic lupus erythematosus and their relatives and spouses. Rheumatology (Oxford). 39:2000;427-431.
30. Raine C.S., Cannella B., Hauser S.L., Genain C.P. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation. Ann. Neurol. 46:1999;144-160.
31. Rankin E.C., Isenberg D.A. IgA deficiency and SLE: prevalence in a clinic population and a review of the literature. Lupus. 6:1997;390-394.
32. Reindl M., Linington C., Brehm U., Egg R., Dilitz E., Deisenhammer F., Poewe W., Berger T. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. Brain. 122(Pt 11):1999;2047-2056.
33. Rieckmann P., Albrecht M., Kitze B., Weber T., Tumani H., Broocks A., Luer W., Helwig A., Poser S. Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann. Neurol. 37:1995;82-88.
34. Schluesener H.J., Sobel R.A., Linington C., Weiner H.L. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J. Immunol. 139:1987;4016-4021.
35. Sellebjerg F., Madsen H.O., Frederiksen J.L., Ryder L.P., Svejgaard A. Acute optic neuritis: myelin basic protein and proteolipid protein antibodies, affinity, and the HLA system. Ann. Neurol. 38:1995;943-950.
36. Spielman R.S., McGinnis R.E., Ewens W.J. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 52:1993;506-516.
37. Stefferl A., Brehm U., Storch M., Lambracht-Washington D., Bourquin C., Wonigeit K., Lassmann H., Linington C. Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the "resistant" Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response. J. Immunol. 163:1999;40-49.
38. Sun J., Link H., Olsson T., Xiao B.G., Andersson G., Ekre H.P., Linington C., Diener P. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. J. Immunol. 146:1991;1490-1495.
39. Tienari P.J., Wikstrom J., Koskimies S., Partanen J., Palo J., Peltonen L. Reappraisal of HLA in multiple sclerosis: close linkage in multiplex families. Eur. J. Hum. Genet. 1:1993;257-268.
40. Tishler M., Moutsopoulos H.M., Yaron M. Genetic studies of anti-Ro (SSA) antibodies in families with rheumatoid arthritis. J. Rheumatol. 19:1992;234-236.
41. van der Linden M.W., Westendorp R.G., Zidane M., Meheus L., Huizinga T.W. Autoantibodies within families of patients with systemic lupus erythematosus are not directed against the same nuclear antigens. J. Rheumatol. 28:2001;284-287.
42. von Budingen H.C., Tanuma N., Villoslada P., Ouallet J.C., Hauser S.L., Genain C.P. Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination. J. Clin. Immunol. 21:2001;155-170.
43. Warren K.G., Catz I. Relative frequency of autoantibodies to myelin basic protein and proteolipid protein in optic neuritis and multiple sclerosis cerebrospinal fluid. J. Neurol. Sci. 121:1994;66-73.
44. Weinshenker B.G., Santrach P., Bissonet A.S., McDonnell S.K., Schaid D., Moore S.B., Rodriguez M. Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study. Neurology. 51:1998;742-747.
45. Weissert R., Wallstrom E., Storch M.K., Stefferl A., Lorentzen J., Lassmann H., Linington C., Olsson T. MHC haplotype-dependent regulation of MOG-induced EAE in rats. J. Clin. Invest. 102:1998;1265-1273.
46. Xiao B.G., Linington C., Link H. Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls. J. Neuroimmunol. 31:1991;91-96.
47. Yang H.T., Bergsteinsdottir K., Wernhoff P., Linington C., Pettersson U., Holmdahl R. Genetic linkage analysis of the antibody responses to myelin basic protein and myelin oligodendrocyte glycoprotein in rats immunized with rat spinal cord homogenate. J. Neuroimmunol. 117:2001;21-29.